2025-03-07 19:57:41,149 [INFO] patent_service - Starting database setup.
2025-03-07 19:57:41,154 [INFO] patent_service - All tables created or ensured to exist.
2025-03-07 19:57:41,154 [INFO] patent_service - Starting to parse JSONL file: data/SerpAPI/patent_data.jsonl
2025-03-07 19:57:41,508 [INFO] patent_service - Finished parsing and inserting data from JSONL.
2025-03-07 19:57:41,509 [INFO] root - [INFO] First 5 patents in DB:
2025-03-07 19:57:41,509 [INFO] root -   -> patent_id=US20190160148A1 | title=Combination of pembrolizumab and abemaciclib for the treatment of cancer | priority_date=2016-05-23 00:00:00
2025-03-07 19:57:41,509 [INFO] root -   -> patent_id=US20210347889A1 | title=Dosing regimen of anti-lag3 antibody and combination therapy with anti-pd-1 antibody for treating cancer | priority_date=2018-11-05 00:00:00
2025-03-07 19:57:41,509 [INFO] root -   -> patent_id=US20180333503A1 | title=Anti-folr1 immunoconjugates and anti-pd-1 antibody combinations | priority_date=2017-05-16 00:00:00
2025-03-07 19:57:41,509 [INFO] root -   -> patent_id=US20210403557A1 | title=Dosing regimen of anti-tigit antibody for treatment of cancer | priority_date=2018-11-05 00:00:00
2025-03-07 19:57:41,509 [INFO] root -   -> patent_id=US20170089914A1 | title=Anti-pembrolizumab antibodies | priority_date=2015-09-25 00:00:00
2025-03-08 05:12:54,608 [INFO] database_constraction.patent_service - Starting database setup.
2025-03-08 05:12:54,609 [INFO] database_constraction.patent_service - All tables created or ensured to exist.
2025-03-08 05:12:54,609 [INFO] database_constraction.patent_service - Starting to parse JSONL file: data/SerpAPI/patent_data.jsonl
2025-03-08 05:12:54,958 [INFO] database_constraction.patent_service - Finished parsing and inserting data from JSONL.
2025-03-08 05:12:54,959 [INFO] root - [INFO] First 5 patents in DB:
2025-03-08 05:12:54,959 [INFO] root -   -> patent_id=US20190160148A1 | title=Combination of pembrolizumab and abemaciclib for the treatment of cancer | priority_date=2016-05-23 00:00:00
2025-03-08 05:12:54,959 [INFO] root -   -> patent_id=US20210347889A1 | title=Dosing regimen of anti-lag3 antibody and combination therapy with anti-pd-1 antibody for treating cancer | priority_date=2018-11-05 00:00:00
2025-03-08 05:12:54,959 [INFO] root -   -> patent_id=US20180333503A1 | title=Anti-folr1 immunoconjugates and anti-pd-1 antibody combinations | priority_date=2017-05-16 00:00:00
2025-03-08 05:12:54,959 [INFO] root -   -> patent_id=US20210403557A1 | title=Dosing regimen of anti-tigit antibody for treatment of cancer | priority_date=2018-11-05 00:00:00
2025-03-08 05:12:54,959 [INFO] root -   -> patent_id=US20170089914A1 | title=Anti-pembrolizumab antibodies | priority_date=2015-09-25 00:00:00
2025-03-08 05:25:47,874 [INFO] database_constraction.patent_service - Starting database setup for all tables.
2025-03-08 05:25:47,875 [INFO] database_constraction.patent_service - All tables created or ensured to exist successfully.
2025-03-08 05:25:47,875 [INFO] database_constraction.patent_service - Starting to parse JSONL file: data/SerpAPI/patent_data.jsonl
2025-03-08 05:25:48,225 [INFO] database_constraction.patent_service - Finished parsing and inserting data from JSONL.
2025-03-08 05:25:48,226 [INFO] root - [INFO] First 5 patents in DB:
2025-03-08 05:25:48,226 [INFO] root -   -> patent_id=US20190160148A1 | title=Combination of pembrolizumab and abemaciclib for the treatment of cancer | priority_date=2016-05-23 00:00:00
2025-03-08 05:25:48,226 [INFO] root -   -> patent_id=US20210347889A1 | title=Dosing regimen of anti-lag3 antibody and combination therapy with anti-pd-1 antibody for treating cancer | priority_date=2018-11-05 00:00:00
2025-03-08 05:25:48,226 [INFO] root -   -> patent_id=US20180333503A1 | title=Anti-folr1 immunoconjugates and anti-pd-1 antibody combinations | priority_date=2017-05-16 00:00:00
2025-03-08 05:25:48,226 [INFO] root -   -> patent_id=US20210403557A1 | title=Dosing regimen of anti-tigit antibody for treatment of cancer | priority_date=2018-11-05 00:00:00
2025-03-08 05:25:48,226 [INFO] root -   -> patent_id=US20170089914A1 | title=Anti-pembrolizumab antibodies | priority_date=2015-09-25 00:00:00
